Services
Senior scientific advisory across experiments, data, and strategic decision-making at the intersection of immunology and AI.
ImmSilico provides expert guidance for complex immunology-driven research programmes, where experimental design, data complexity, and biological uncertainty matter.
Our advisory work draws on the scientific framework outlined on the Home page, and is delivered through flexible modes of engagement tailored to the needs of each project.
Areas of Advisory Involvement
Scientific Decision Architecture
Decide with clarity under uncertainty.
We help founders and scientific leads make high-stakes biological and translational decisions before irreversible resources are committed.
Go/No-go target progression reviews
Platform and technology viability assessments
Data sufficiency and evidentiary threshold analysis
Independent stress-testing of mechanistic claims
Typical output: structured decision memo with risk mapping and recommendation pathway.
Experimental Design & Strategh
Design experiments that generate durable insight.
We align biological questions, measurement technologies, and statistical structure before large-scale data generation begins.
Hypothesis clarification and uncertainty mapping
Fit-for-purpose technology selection
Study design blueprints and power strategy
Pre-execution feasibility and risk assessment
Typical output: experimental design architecture document.
AI-Tailored Data Integration
Integrate complexity without losing mechanism.
We design AI and data frameworks that remain interpretable, mechanistically grounded, and decision-relevant.
Pre-analysis planning prior to data acquisition
Cross-modality data architecture
AI/ML selection and validation
Interpretability and generalisability safeguards
Typical output: integration and interpretability framework.
How Engagements Typically Work
We work with clients in flexible ways, depending on the nature, scale, and complexity of the scientific challenge.
Our involvement may range from focused advisory input on a specific experimental or analytical question, through ongoing strategic support across a research programme, to deeper collaboration around complex, immunology-driven decisions at critical stages of discovery or translation.
Each engagement is shaped by the scientific context and requirements of the project, rather than a fixed service model. If you are facing a complex immunology-driven decision across research, translation, or strategy, we invite an initial discussion.
Initiate a Discussion
If you are facing complex immunology-driven decisions across research, translation, or strategy, we would be happy to explore how our advisory input could help.